AJANTPHARMBSEAJANTA PHARMA LIMITED· PharmaceuticalsHighNegative
Announced Tue, 6 Oct, 2026 · 10:32 IST

Ajanta Pharma promoter creates pledge on 4.6 lakh shares

Pledge Above 50pctOwnership Changes View source PDFExplain this filing

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹3499.70
prior close
₹3523.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.0-0.0-0.1+2.4-1.8————————
Up moveDown movePending
AI summary

Aayush Agrawal, promoter and trustee of Aayush Agrawal Trust, has created a pledge on 4,60,000 equity shares (0.37% of total share capital) of Ajanta Pharma. The pledge was created on 28-Sep-2026 for the issue of Non-Convertible Debentures (NCDs), with CTL Trusteeship Ltd as the pledgee. Post this event, 1,21,02,386 shares (9.69% of total share capital) held by the trust are now encumbered out of its 1,41,12,924 share (11.29%) holding, meaning around 86% of the trust's stake is pledged.

Likely market impact

Pledge for NCD issue is routine borrowing-related encumbrance, but encumbered promoter holding is now high at about 86% of this trust's stake.